Mawle, A C, Nisenbaum, R, Dobbins, J G et al. · The Journal of infectious diseases · 1997 · DOI
Researchers compared immune system measurements between ME/CFS patients and healthy controls to see if immune differences could reliably detect the illness. While previous studies reported many immune differences, this careful study found most standard immune tests showed no difference between patients and controls. However, when they looked at specific subgroups—such as patients whose illness started suddenly versus gradually—they did find some immune differences, suggesting that ME/CFS may not be a single uniform immune condition.
This study is important because it demonstrates that immune abnormalities in ME/CFS are not universal across all patients—they depend on disease presentation type and current clinical state. This finding supports the concept that ME/CFS may comprise distinct biological subtypes, which has significant implications for both research design and future diagnostic and treatment strategies tailored to specific patient phenotypes.
This study does not prove that immune dysfunction plays no role in ME/CFS, only that standard immune measures are not uniformly abnormal across all patients. The findings do not establish causation or identify which immune abnormalities, if any, drive symptom production. The stratification findings are exploratory and require confirmation in prospectively designed studies with larger sample sizes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.